Mednet Reports

The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

MEDICAL FRONTIERS - Options X for the Control of Influenza (ISIRV 2019)

Innovazioni tecnologiche sull'influenza stagionale per proteggere il mondo dalla prossima pandemia

Singapore / 28 agosto - 1 settembre 2019

Singapore – Secondo l'Organizzazione Mondiale della Sanità (OMS) la prossima pandemia influenzale è solo questione di tempo (Global Influenza Strategy 2019–2030). Nonostante settant'anni di progressi nella ricerca...

MEDICAL FRONTIERS - Options X for the Control of Influenza (ISIRV 2019)

Las innovaciones científicas en la gripe estacional arman al mundo para combatir la siguiente pandemia

Singapur / 28 de agosto – 1 de septiembre de 2019

Singapur – Si hablamos de la siguiente pandemia de gripe, “la cuestión no es si la habrá, sino cuándo,” según la Organización Mundial de la Salud (OMS) en su Estrategia Mundial contra la...

MEDICAL FRONTIERS - Options X for the Control of Influenza (ISIRV 2019)

Inovações científicas na influenza sazonal dão ao mundo armas para lutar contra a próxima pandemia

Singapura / 28 de agosto a 1º de setembro de 2019

Singapura – De acordo com a Organização Mundial de Saúde (OMS), na sua Estratégia Global contra a Influenza 2019-2030, a dúvida quanto à próxima pandemia de influenza não...

MEDICAL FRONTIERS - Options X for the Control of Influenza (ISIRV 2019)

Ground-breaking Science in Seasonal Influenza Arms the World to Fight Next Pandemic

Singapore / August 28-September 1, 2019

Singapore – The next influenza pandemic is “a matter of when not if,” according to the World Health Organization (WHO) in its Global Influenza Strategy 2019–2030. Despite seven decades of advances in flu research,...

MEDICAL FRONTIERS - EULAR European Congress of Rheumatology

Changing Landscape in the Treatment of Axial Disease in Patients with Axial PsA and axSpA

Madrid, Spain / June 12-15, 2019

Madrid – Axial manifestations are present in a high proportion (25%-75%) of patients with psoriatic arthritis (PsA). NSAIDs continue to be the mainstay of treatment in the early phases of axial PsA and axial spondyloarthritis (axSpA)....

PRIORITY PRESS - The Canadian Immunization Conference (CIC)

Overcoming Low Influenza Vaccine Effectiveness

Ottawa, Ontario / December 4-6, 2018

Ottawa - Increasing the effectiveness of influenza vaccines is one of the core strategies for dealing with future seasonal influenza outbreaks and pandemics. While egg-based manufacturing processes for influenza vaccines have been in place...

MEDICAL FRONTIERS - Annual Meeting of the American Society of Hematology

A New Era of Chemotherapy-free Treatments Emerges for Chronic Lymphocytic Leukemia

Atlanta, Georgia / December 9-12, 2017

Atlanta - The recent approvals of many effective, well-tolerated novel agents for chronic lymphocytic leukemia (CLL) have changed the treatment landscape. Researchers are learning how best to sequence and potentially combine novel...

MEDICAL FRONTIERS - Annual Meeting of the American College of Rheumatology

Update on the Impact of IL-17A Inhibition on Disease Severity and Structural Changes in Axial Spondyloarthritis

San Diego, California / November 4-7, 2017

San Diego - Joint symptoms and structural joint damage are two targets of the treatment of axial spondyloarthritis (axSpA), which encompasses psoriatic arthritis and ankylosing spondylitis. Inhibition of interleukin-17A, a key cytokine...

MEDICAL FRONTIERS - 26th European Academy of Dermatology and Venereology Congress

A Long-Term Update with IL-17A Inhibition

Geneva, Switzerland / September 13-17, 2017

Geneva - Long-term data are emerging with the interleukin (IL)-17A inhibitors in the treatment of patients with moderate to severe plaque psoriasis and psoriatic arthritis. These findings, from open-label extensions of phase 2 and phase 3...

MEDICAL FRONTIERS - 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO)

A New Era Emerges In Melanoma Control, Including Brain Metastases

Chicago, Illinois / June 2-6, 2017

Chicago - A growing proportion of patients with advanced metastatic melanoma are surviving for long periods due largely to two approaches. One involves combining therapies targeted at the BRAF and MEK pathways. The other involves...

PAGE 2 OF 109   1 2 3 4 5 6 7 8 9 10 ...